PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors

Recruiting now · Not applicable

Conditions studied: Cancer, Solid Malignancies

In brief

To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.

Key facts

Study ID

NCT06684028

Run by

Affiliated Hospital of Jiangnan University

People needed

30

Starts

2023-07-12

Expected to finish

2025-07-31

Last updated by the study team

2025-01-22

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subjects sign the informed consent voluntarily and can complete the test according to the protocol requirements;
• Age 18-85 years old, male or female;
• Clinically diagnosed as malignant tumor, diagnostic criteria refer to biopsy or other imaging such as CT and MRI;
• ECOG score is 0-3 points;

You may not qualify if…

• Patients with a history or allergic constitution to any component of the developer, including alcohol;
• pregnant or lactating women;
• Patients with mental illness or related history;
• Patients who cannot or cannot undergo a PET/CT scan;

Where it is running

• Affiated Hospital of Jiangnan University — Wuxi, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.